ArticleBMC veterinary research2026
Emergence of multidrug-resistant Staphylococcus epidermidis in Nile tilapia (Oreochromis spp.): virulence, antimicrobial resistance, and nanoparticle-based control.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStaphylococcus epidermidis represents an emerging zoonotic threat impacting aquatic ecosystems, livestock, and human health. This study investigated the causative agent behind summer mortality episodes affecting cultured Oreochromis spp. (180 ± 20 g) in Egyptian fish farms, where diseased specimens exhibiting characteristic ulcerative dermatopathy were collected from Ismailia governorate.
resultsComprehensive diagnostics excluded TiLV and NNV, while bacteriological analysis identified Gram-positive cocci producing distinctive white hemolysis-negative colonies on blood agar and red colonies on mannitol salt agar. Polyphasic characterization confirmed the isolates as S. epidermidis (16 S rRNA GenBank MN153038), marking the first genomic record of this pathogen in tilapia. Antimicrobial profiling revealed alarming multidrug resistance (54.5% of tested agents), including resistance to β-lactams (oxacillin, ampicillin, and cefoxitin) that suggests possible methicillin-resistant (MRSE) phenotypes, despite retained vancomycin susceptibility (MIC = 4 µg/mL). Controlled challenge trials demonstrated dose- and route-dependent virulence, with scale removal during immersion exposure precipitated 95% mortality in fingerlings (2.3 ± 0.75 g) versus 55% in intact fish. In contrast, intraperitoneal injection caused 40–50% mortality in adults/juveniles. Notably, silver nanoparticles (AgNPs) exhibited size-dependent antimicrobial activity: 10-nm AgNPs showed superior efficacy (MIC = 1.25 µg/mL; MBC = 2.5 µg/mL) compared to 100-nm AgNPs (MIC = 10 µg/mL) and zinc oxide nanoparticles (MIC = 125 µg/mL). The enhanced activity of smaller AgNPs is attributed to their greater surface area and improved biofilm penetration.
conclusionThese results highlight S. epidermidis as an emerging threat in tilapia aquaculture, particularly given its multidrug resistance. The demonstrated efficacy of AgNPs, especially at smaller particle sizes, offers a promising alternative for controlling such resistant infections in aquaculture settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.